Antiretroviral therapy coverage in Kazakhstan
Kazakhstan: Antiretroviral therapy coverage was 74.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage in Kazakhstan, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
In 2024, antiretroviral therapy coverage in Kazakhstan stood at 74.0%. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 5.7% on the previous year and up 270.0% over ten years.
Over the whole period, antiretroviral therapy coverage in Kazakhstan peaked at 74.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Kazakhstan 66th out of 143 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage in Kazakhstan, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 3.0% | — |
| 2006 | 3.0% | +0.0% |
| 2007 | 4.0% | +33.3% |
| 2008 | 5.0% | +25.0% |
| 2009 | 7.0% | +40.0% |
| 2010 | 8.0% | +14.3% |
| 2011 | 10.0% | +25.0% |
| 2012 | 13.0% | +30.0% |
| 2013 | 17.0% | +30.8% |
| 2014 | 20.0% | +17.6% |
| 2015 | 24.0% | +20.0% |
| 2016 | 28.0% | +16.7% |
| 2017 | 38.0% | +35.7% |
| 2018 | 47.0% | +23.7% |
| 2019 | 52.0% | +10.6% |
| 2020 | 56.0% | +7.7% |
| 2021 | 60.0% | +7.1% |
| 2022 | 65.0% | +8.3% |
| 2023 | 70.0% | +7.7% |
| 2024 | 74.0% | +5.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.2% | 0.0% | 7.0% | 10 |
| 2010s | 25.7% | 8.0% | 52.0% | 10 |
| 2020s | 65.0% | 56.0% | 74.0% | 5 |
Countries ranked near Kazakhstan
More health data for Kazakhstan
- Un projection of annual infant deaths, annual growth rate -1.35 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3158 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 825.8 deaths per 1,000 people (2090)
- Number of infants who die before age 1 660 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.58 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0485 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.16 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Kazakhstan?
- Antiretroviral therapy coverage in Kazakhstan was 74.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Kazakhstan?
- The highest recorded value was 74.0% in 2024.
- What is the lowest antiretroviral therapy coverage recorded in Kazakhstan?
- The lowest recorded value was 0.0% in 2000.
- How does Kazakhstan rank for antiretroviral therapy coverage?
- Kazakhstan ranks 66th out of 143 countries with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Kazakhstan?
- Over the last ten years it is up 270.0%. The long-run trend across the full record is volatile.
- Where does this Kazakhstan data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.